ABT vs SSTK · P/E 25, rev $44.33B vs rev $421.0M
Abbott Laboratories (ABT) versus Shutterstock (SSTK) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Shutterstock (SSTK) is a internet content & information company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SSTK revenue for 2026-06-30 was $421.0M. Net income was -$203.5M. SSTK currently screens at market cap $474.7M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SSTK currently screens at market cap $474.7M.
Not investment advice. Open the ABT and SSTK stock pages for the full models.
Not investment advice.